Apolipoprotein E2 Genotype Is Associated with a 2-Fold Increase in the Incidence of Type 2 Diabetes Mellitus: Results from a Long-Term Observational Study

<figure class="figure-group responsive"><div class="sub-figure" id="a"><object data="https://static.hindawi.com/articles/jl/volume-2019/1698610/figures/1698610.fig.002a.svgz" name="1698610.fig.002a" type="image/svg+xml"></object><div class="fig-label"><b>(a) </b>CV mortality, MI, and stroke</div></div><div class="sub-figure" id="b"><object data="https://static.hindawi.com/articles/jl/volume-2019/1698610/figures/1698610.fig.002b.svgz" name="1698610.fig.002b" type="image/svg+xml"></object><div class="fig-label"><b>(b) </b>T2DM incidence</div></div></figure>

<p><i>Kaplan–Meier estimates of (a) CV mortality, MI and stroke and (b) T2DM incidence in the different APOE genotypes. </i>CV: cardiovascular; MI: myocardial infarction; T2DM: diabetes mellitus; APOE: apolipoprotein E.</p>

Journal of Lipids

fig2

Figure 2

Figure 2: Apolipoprotein E2 Genotype Is Associated with a 2-Fold Increase in the Incidence of Type 2 Diabetes Mellitus: Results from a Long-Term Observational Study 

Figure 2 | Apolipoprotein E2 Genotype Is Associated with a 2-Fold Increase in the Incidence of Type 2 Diabetes Mellitus: Results from a Long-Term Observational Study 